Showing results (121-130 of 136) with videos related to

Sort By:
Pageof 14
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2002
Structural identification and biological activity of 7-methyl-10,11-ethylenedioxy-20(S)-camptothecin, a photodegradant of lurtotecanWalter J Loos, Jaap Verweij, Diederik F S Kehrer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 1995
Expression of the multidrug resistance-associated protein (MRP) gene in human cancersK Nooter, A M Westerman, M J Flens, et al.
European Journal of Cancer (Oxford, England : 1990)|December 26, 2001
Modulation of cisplatin pharmacodynamics by Cremophor EL: experimental and clinical studiesH Gelderblom, W J Loos, J Verweij, et al.
Anti-Cancer Drugs|April 9, 1999
Sparse-data set analysis for irinotecan and SN-38 pharmacokinetics in cancer patients co-treated with cisplatinR H Mathijssen, R J van Alphen, M J de Jonge, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 1998
Disposition of Cremophor EL in humans limits the potential for modulation of the multidrug resistance phenotype in vivoA Sparreboom, J Verweij, M E van der Burg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 1998
Irinotecan (CPT-11) metabolism and disposition in cancer patientsA Sparreboom, M J de Jonge, P de Bruijn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 14, 1998
Differential modulation of cisplatin accumulation in leukocytes and tumor cell lines by the paclitaxel vehicle Cremophor ELA I de Vos, K Nooter, J Verweij, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1996
Expression of the multidrug resistance-associated protein (MRP) gene in primary non-small-cell lung cancerK Nooter, F T Bosman, H Burger, et al.
European Journal of Cancer (Oxford, England : 1990)|May 15, 2002
Disposition of docetaxel in the presence of P-glycoprotein inhibition by intravenous administration of R101933L van Zuylen, A Sparreboom, A van der Gaast, et al.
British Journal of Cancer|January 1, 1997
The prognostic significance of expression of the multidrug resistance-associated protein (MRP) in primary breast cancerK Nooter, G Brutel de la Riviere, M P Look, et al.
Pageof 14